Mark Fletcher, EVP & General Counsel at GENEREX BIOTECHNOLOGY CORP (GNBT), bought 8,700 shares at $0.52 ($5K) on 2010-01-04, disclosed to the SEC on 2010-01-04.
Open-market purchase of $5k GNBT by EVP & General Counsel. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| GNBT | BUY | 2009-01-12 | $4K | — | Filing → |
| GNBT | BUY | 2008-11-03 | $9K | — | Filing → |
| GNBT | SELL | 2008-04-21 | $263K | — | Filing → |